期刊文献+

组织因子抑制子基因局部转移对兔颈总动脉内膜增生的影响

Effects of local delivery of tissue factor pathway inhibitor (TFPI) gene on neointimal proliferation of rabbit carotid artery after balloon injury
下载PDF
导出
摘要 目的:研究组织因子抑制子(TFPI)基因局部转移对兔颈总动脉损伤后内膜增生的影响。方法:36只新西兰纯种雄性大白兔随机分为腺病毒空载组,包载组织因子抑制子(TFPI)基因腺病毒组和生理盐水组(每组12只)。用球囊导管对实验兔行颈总动脉损伤,术后14天取病变血管,免疫组化染色观察表明TFPI在转移局部表达成功;病变最明显处取标本进行HE染色,光学显微镜下观察血管内膜增生,以计算机图像分析系统分析血管内膜﹑中膜和腔面积的变化,计算内膜增生细胞核抗原增殖指数。结果:TFPI基因局部转移后血管内膜面积明显减少,中膜面积不变,血管腔面积增大。结论:TFPI基因局部转移显著抑制颈总动脉损伤处血管内膜的增生,有可能防治再狭窄。 Objective: To evaluate the influence of local delivery of tissue factor pathway inhibitor gene on intimal hyperplasia after balloon injury. Methods: Thirty-six male New Zealand white rabbits were divided into three groups, saline, adenovirus-defect and TFPI gene treated group. Balloon catheter was used to induce injury to the carotid artery of rabbits and saline, adenovirus-defect and TFPI gene were locally delivered on injury site. Fourteen days after operation, the local injury vessel was removed and harvested for pathological analysis and immunohistochemical staining. Automatic image analysis system was used to detect the changes of intimal, medium, luminal area, and the proliferation index of proliferating cell nuclear antigen (PCNA). Results: Morphological analysis showed intimal hyperplasia remarkably decrease, along with the proliferation index of PCNA significantly reduction and luminal area augment significantly in TFPI gene treated group compared with saline and adenovirus-defect group. Conclusion: Local TFPI gene transferring may reduce the expression of PCNA,and decrease the intimal hyperplasia and enlarge the luminal area in carotid artery of rabbits.
出处 《南京医科大学学报(自然科学版)》 CAS CSCD 北大核心 2006年第11期1025-1027,F0002,共4页 Journal of Nanjing Medical University(Natural Sciences)
基金 江苏省教育厅自然科学基金资助(01KJB320006)
关键词 组织因子抑制子 球囊损伤 内膜增生 tissue factor pathway inhibitor balloon injury intimal hyperplasia
  • 相关文献

参考文献12

  • 1Takeshi Y, Akiko S, Yu-kl, et al. Thrombomodulin and tissue factor pathway inhibitor in endocardlum of rapidly paced rat atria[J]. Circulation, 2003,108:2450-2452
  • 2Jan S, Thomas FL, Felix CT, et al. Tissue factor in cardiovascular diseases.molecular mechanisms and clinical implications [ J ]. Circulation, 2006,113 : 722-731
  • 3Jeffrey IW. New anticoagulants for treatment of venous thromboembolism[J], circulation, 2004, 110:119-126
  • 4Golino P, Cirilo P, Calabro P, et al. Expression of exogenous tissue factor pathway inhibitor in vivo suppres sthrombus formation in injured rabbit caroatid arteries[J].J AM Coil Cardiol, 2001,38 : 569-576
  • 5Lafont A, Durand E, Vilde F, et al. Thrombus generation after adenovirus-mediated gene transfer into atherosclerotic arteries [J]. Hum Gene Ther, 1998,9:2795-2800
  • 6Randal JW, Peter FB, Zuo JX, et al. Deficiency of Tissue Factor Pathway Inhibitor Promotes Atherosclerosis and Thrombosis in Mice [J]. Circulation, 2001,103:3044-3046
  • 7邹建刚,王志荣,黄元铸,杨国平,冷静,曹克将.白藜三醇对血管内皮剥脱术后内膜增殖的影响[J].南京医科大学学报(自然科学版),2003,23(5):470-472. 被引量:2
  • 8Ravindra SA. Allele frequencies of tissue factor pathway inhibitor polymorphisms in African, Hispanic and Caucasian populations [J]. Thromb Haemost,2002,88 : 875-877
  • 9Morange PE, Renucci JF. Plasma levels of free and total TFPI, relationship with cardiovascular risk factors and endothelial cell markers [J]. Thromb Haemost, 2001, 85(6) :999-1003
  • 10Massino R, Paolo G, Plinio C, et al. Endogenous tissue factor pathway inhibitor modulates thrombus formation in an in vivo model of rabbit carotid artery stenosis and endothelial injury [ J ]. Circulation, 2000,102 : 113-117

二级参考文献9

  • 1Liu MW, tLoubin GS, King SB. Restenosis after coronary angioplasty: potential biologic determinants and role of intimal hyperplasia [J]. Circulation,1989,79:1374-1387.
  • 2Gravanis MB, Koubin GS. Histopathologic phenomena at the site of percuuaneous transluminal coronary angioplasty: the problem of restenosis[J]. Hum Pathol,1989,20 : 477-485.
  • 3Tradif JC, Cote G, Lesperance J, et al. Probucol and multivitamins in the prevention of restenosis after coronary angioplasty [J]. N Engl J Med,1997,337:365-372.
  • 4Zou JG, Huang YZ, Chen Q, et al. Suppression of mitogenesis and regulation of cell cycle traverse by resveratrol in cultured smooth muscle cells [J]. Int J Oncol, 1999,15: 647-651.
  • 5Fanelli C, Aronoff R.Restenosis after coronary angioplasty[J ]. Am Heart J, 1990,119:357-368.
  • 6Laurence A, Harker MD. Role of phtelets and thrombosis in mechanisms of acute occlusion and restenosis after angioplasty[J]. Am J Cardiol,1987,60:20B-28B.
  • 7Calife RM, Fortin DF, Frid DJ, et al. Restenosis after coronary angioplasty: an overview [J]. JACC,1991,17:2B-13B.
  • 8Zou JG, Huang YZ, Chen Q, et al. Resveratrol inhibits copper-induced and azo compound-initiated oxidative modification of human low lipoprotein [J].Biochem Mol Biol Int, 1999,47 : 1089-1096.
  • 9Hsieh TC, Juan G, Darzynkiewiez Z,et al . Resveratrol increases nitric oxide synthase, induces accumulation of p53 and p21WAF1/CIP1, and suppreses cultured bovine pulmonary artery endothelial cell proliferation by perturbing progression through S and G2[J]. Canc Res, 1999,59:2596-2601.

共引文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部